Posted On July 25, 2024 /
By Debbie Muse / Posted in Blog
Robert C. Wang, MD, Presented Initial Study Results of New Non-infectious Uveitis Treatment at ASRS 2024 Annual Meeting
Texas Retina’s Robert C. Wang, MD, presented “Safety and Efficacy of Brepocitinib, a TYK2/JAK1 Inhibitor, in Active Non-Infectious Uveitis: 24-Week Results from a 52-Week Phase II Study (NEPTUNE)” at the 2024 Annual
read more
Posted On March 26, 2021 /
By Debbie Muse / Posted in Blog
Dr. Wang’s Research Published in British Journal of Ophthalmology
Texas Retina Associates’ Robert C. Wang, MD, co-authored an article titled “Extension Study of the Safety and Efficacy of CLS-TA for Treatment of Macular Edema Associated with Non-infectious Uveitis (MAGNOLIA)” in the
read more
Posted On March 12, 2021 /
By Debbie Muse / Posted in Blog
Dr. Wang Co-authored Article on New Non-infectious Uveitis Treatment Published in Acta Ophthalmologica Journal
Texas Retina Associates’ Robert C. Wang, MD, co-authored an article titled “Management of Repository Corticotropin Injection Therapy for Non‐infectious Uveitis: A Delphi Study” in the March 2021 issue of the medical journal
read more